Anorexigenic Peptides in Health and Disease

作者: Emrah Caylak

DOI: 10.1002/9780470015902.A0024165

关键词: OxyntomodulinInternal medicineNeuropeptideMedicineLeptinMelanocortinsAmylinPeptide YYPancreatic polypeptideEndocrinologyObestatin

摘要: The regulation of satiety and body weight involves highly complex multiple interactions between the gastrointestinal tract, adipose tissue central nervous system. Several neuropeptides released by hypothalamic neurons including corticotropin-releasing factor, α-melanocyte stimulating hormone, corticotropin, brain-derived neurotrophic cocaine- amphetamine-regulated transcript, B, W nesfatin-1; hormones obestatin, pancreatic polypeptide, amylin, cholecystokinin, peptide YY, oxyntomodulin, glucagon-like peptide-1 are reviewed in this article, emphasising both their effects on regulating satiety, physiological roles many systems. The dysfunctions anorexigenic peptides those processes will result metabolic disorders such as obesity type 2 diabetes. purpose review is also to consider important nesfatin-1, amylin obesity-related pathophysiological conditions. Key Concepts: Satiety satisfied feeling being full after eating. It refers inhibition eating following a meal. Neuropeptides play major role feeding CRF, melanocortins, BDNF, CART, nesfatin-1. Anorexigenic tract food intake CCK, OXM GLP-1. Obesity contributor cardiovascular disease, (type 1 or diabetes) various cancers. Obesity predisposes humans some chronic diseases diabetes, diseases, cancers it shortens life duration increases mortality rates. Understanding pathological health disease allow us find potential therapeutic targets for treatment disorders. Keywords: Satiety; leptin; CRF; melanocortins; BDNF; CART; NPB; NPW; nesfatin-1; obestatin; pancreatic polypeptide; amylin; CCK; peptide YY; OXM; GLP-1; obesity; type diabetes

参考文章(25)
Mari Hondo, Makoto Ishii, Takeshi Sakurai, The NPB/NPW neuropeptide system and its role in regulating energy homeostasis, pain, and emotion. Results and problems in cell differentiation. ,vol. 46, pp. 239- 256 ,(2008) , 10.1007/400_2007_056
Thomas A. Lutz, Roles of amylin in satiation, adiposity and brain development. Lutz, T A (2009). The roles of amylin in satiation, adiposity and brain development. In: Langhans, W; Geary, N. Frontiers in Eating and Weight Regulation. Forum Nutrition: Karger, 64-74.. ,vol. 63, pp. 64- 74 ,(2010) , 10.1159/000264394
Katia Gysling Caselli, María Inés Forray Claps, None, Corticotropin-releasing hormone and urocortin: redundant or distinctive functions? Brain Research Reviews. ,vol. 47, pp. 116- 125 ,(2004) , 10.1016/J.BRAINRESREV.2004.06.001
Keisuke Suzuki, Katherine A Simpson, James S Minnion, Joyceline C Shillito, Stephen R Bloom, The role of gut hormones and the hypothalamus in appetite regulation Endocrine Journal. ,vol. 57, pp. 359- 372 ,(2010) , 10.1507/ENDOCRJ.K10E-077
Robert Krysiak, Bogus?aw Okopie?, Dariusz Belowski, Andrzej Madej, Zbigniew Stanis?aw Herman, Recent insights into body weight control: from physiology to pathology. Journal of Peptide Science. ,vol. 7, pp. 571- 578 ,(2001) , 10.1002/PSC.354
Gillian L. Sowden, Daniel J. Drucker, David Weinshenker, Steven J. Swoap, Oxyntomodulin increases intrinsic heart rate in mice independent of the glucagon-like peptide-1 receptor American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 292, ,(2007) , 10.1152/AJPREGU.00405.2006
Mustafa Ari, Oktay Hasan Ozturk, Yasin Bez, Suleyman Oktar, Dudu Erduran, High plasma nesfatin-1 level in patients with major depressive disorder. Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 35, pp. 497- 500 ,(2011) , 10.1016/J.PNPBP.2010.12.004
Andreas Stengel, Yvette Taché, Minireview: Nesfatin-1—An Emerging New Player in the Brain-Gut, Endocrine, and Metabolic Axis Endocrinology. ,vol. 152, pp. 4033- 4038 ,(2011) , 10.1210/EN.2011-1500
J. P. H. Wilding, Neuropeptides and appetite control. Diabetic Medicine. ,vol. 19, pp. 619- 627 ,(2002) , 10.1046/J.1464-5491.2002.00790.X